What Did One of the Largest Studies of AI and Interval Cancers Find?
Description
This article explores the findings of one of the largest studies of AI and interval cancers, which evaluated Lunit INSIGHT® MMG across 661,695 screening mammograms using data from BreastScreen Norway.
One of the largest studies of AI and interval cancers used data from BreastScreen Norway to evaluate Lunit INSIGHT® MMG across 661,695 screening mammograms. When researchers focused on the 10% of exams with the highest AI scores, the AI flagged 495 interval cancers from a total of 1,110 interval cancers identified in the study.
Why are interval cancers important?
Behind every interval cancer is a woman who left her screening appointment believing everything was normal.
That is why interval cancers remain one of the most challenging areas of breast screening.
How was the study conducted?
Using data from BreastScreen Norway, researchers evaluated Lunit INSIGHT® MMG across 661,695 screening mammograms.
The study used data collected through a highly standardized screening program and included more than six years of follow-up.
How many cancers were included in the study?
Among the screening examinations included in the study:
3,807 were screen-detected cancers.
1,110 were interval cancers.
What did the AI identify?
When the analysis focused on the 10% of exams with the highest AI scores, Lunit INSIGHT® MMG flagged 495 interval cancers.
That's nearly half of all interval cancers identified in the study.
What do these findings mean?
These findings strengthen our confidence that AI can help address one of the most challenging areas of breast screening.
They also provide important insight into the potential role of AI in supporting the detection of interval cancers.
How many mammograms were included in the study?
The study evaluated 661,695 screening mammograms.
Where did the data come from?
Researchers used data from BreastScreen Norway.
How many cancers were included?
The study included 3,807 screen-detected cancers and 1,110 interval cancers.
How many interval cancers were flagged by AI?
When researchers focused on the 10% of exams with the highest AI scores, the AI flagged 495 interval cancers.
How long was the follow-up period?
The study included more than six years of follow-up.
